Diet-induced obesity promotes altered remodeling and exacerbated cardiac hypertrophy following pressure overload
Related Experiment Video
Updated: Apr 5, 2026

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
Katherine M Holzem1, Joseph T Marmerstein1, Eli J Madden1
1Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri, USA.
Insights
Diet-induced obesity exacerbates heart failure progression in mice subjected to pressure overload, linked to JNK1/2 signaling. This highlights how cardiometabolic state impacts heart failure development.
Area of Science:
- Cardiology
- Metabolic Research
- Animal Models
Background:
- Heart failure (HF) is the advanced stage of cardiovascular disease.
- Current animal models of HF often lack the overweight/obese metabolic state common in human patients.
- A need exists for HF models that reflect the human cardiometabolic condition.
Purpose of the Study:
- To develop and investigate a model for cardiac hypertrophy and failure in obese mice.
- To assess if diet-induced obesity (DIO) exacerbates pressure overload-induced cardiac dysfunction.
- To identify molecular pathways involved in aggravated HF pathogenesis in an obese state.
Main Methods:
- Wild-type male mice were fed a high-fat diet (DIO) or normal chow for 10 weeks.
- Cardiac pressure overload was induced via transverse aortic constriction (TAC).
- Cardiac hypertrophy, mechanical function, and electrophysiology were analyzed 5-6 weeks post-surgery.
Main Results:
- DIO mice with TAC showed significantly exacerbated cardiac hypertrophy and systolic dysfunction compared to chow-fed TAC mice.
- Normalized heart weight increased by 55.8% and fractional shortening decreased by 30.9% in DIO TAC hearts versus chow TAC.
- Exacerbated remodeling in DIO TAC hearts was associated with early activation of the c-Jun-N-terminal kinase (JNK1/2) signaling pathway.
Conclusions:
- Diet-induced obesity significantly aggravates cardiac hypertrophy and heart failure progression following pressure overload.
- The JNK1/2 signaling pathway is implicated in the exacerbated cardiac remodeling observed in obese mice.
- Cardiometabolic state critically influences the pathogenesis of heart failure.
Abstract:
Heart failure (HF) is the end stage of cardiovascular disease, in which hypertrophic remodeling no longer meets cardiac output demand. Established animal models of HF have provided insights into disease pathogenesis. However, these models are developed on dissimilar metabolic backgrounds from humans - patients with HF are frequently overweight or obese, whereas animal models of HF are typically lean. Thus, we aimed to develop and investigate model for cardiac hypertrophy and failure that also recapitulates the cardiometabolic state of HF in humans. We subjected mice with established diet-induced obesity (DIO) to cardiac pressure overload provoked by transverse aortic constriction (TAC). Briefly, we fed WT male mice a normal chow or high-fat diet for 10 weeks prior to sham/TAC procedures and until surgical follow-up. We then analyzed cardiac hypertrophy, mechanical function, and electrophysiology at 5-6 weeks after surgery. In DIO mice with TAC, hypertrophy and systolic dysfunction were exacerbated relative to chow TAC animals, which showed minimal remodeling with our moderate constriction intensity. Normalized heart weight was 55.8% greater and fractional shortening was 30.9% less in DIO TAC compared with chow TAC hearts. However, electrophysiologic properties were surprisingly similar between DIO sham and TAC animals. To examine molecular pathways activated by DIO and TAC, we screened prohypertrophic signaling cascades, and the exacerbated remodeling was associated with early activation of the c-Jun-N-terminal kinase (JNK1/2) signaling pathway. Thus, DIO aggravates the progression of hypertrophy and HF caused by pressure overload, which is associated with JNK1/2 signaling, and cardiometabolic state can significantly modify HF pathogenesis.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy

